Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence - Top-Institutions - MDSpire

Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence

  • By

  • Akif Mirioglu

  • Kaan Ali Dalkir

  • Mehmet Yigit Gokmen

  • Melih Bagir

  • Kivilcim Eren Ates

  • Mehmet Ali Deveci

  • Gülfiliz Gönlüşen

  • Hilmi Serdar Ozbarlas

  • June 12, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Çukurova University
    Çukurova University

    Adana, Turkey

    Key Differentiators

    • Orthopedics

  • #2

    Cleveland Clinic Taussig Cancer Institute
    Cleveland Clinic Taussig Cancer Institute

    Cleveland, Ohio

    Key Differentiators

    • Oncology

  • #3

    Levine Cancer Institute, Carolinas HealthCare System
    Levine Cancer Institute, Carolinas HealthCare System

    Charlotte, North Carolina

    Key Differentiators

    • Oncology

  • #4

    University of North Carolina School of Medicine
    University of North Carolina School of Medicine

    Chapel Hill, North Carolina

    Key Differentiators

    • Medicine

  • #5

    Zhujiang Hospital of Southern Medical University
    Zhujiang Hospital of Southern Medical University

    Guangzhou, China

    Key Differentiators

    • Surgery

Original Source(s)

Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence

  • by Akif Mirioglu, Kaan Ali Dalkir, Mehmet Yigit Gokmen, Melih Bagir, Kivilcim Eren Ates, Mehmet Ali Deveci, Gülfiliz Gönlüşen, Hilmi Serdar Ozbarlas

  • June 12, 2026

Related Content

Case Report: Long-term maternal and neonatal outcomes after nivolumab therapy in metastatic tonsillar sarcomatoid squamous cell carcinoma

Case Report: Pediatric nasopharyngeal carcinoma masquerading as benign lymphadenopathy: diagnostic pitfalls in two cases

HOX gene dysregulation in head and neck squamous cell carcinoma: mechanisms, clinical relevance, and future perspectives